Nexsen Names Gleneagles Hospital CEO to Chair Advisory Board
NXN: $0.150 -3.23% · MC: $32M
Nexsen has appointed Gleneagles Hospital Hong Kong CEO Kenneth Tsang as Advisory Board chair and intensive-care kidney injury expert Professor Kwok-ming Ho as a member. The company says the appointments are intended to support development and clinical validation of its diagnostics, including RenalSure, which is targeting a US FDA submission in mid-2027.

Comments